Arvinas, Inc. (ARVN)
7.605
-0.18
(-2.37%)
USD |
NASDAQ |
Sep 25, 14:26
Arvinas Cash and Short Term Investments (Quarterly) : 567.90M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 567.90M |
| March 31, 2026 | 614.90M |
| December 31, 2025 | 685.40M |
| September 30, 2025 | 787.60M |
| June 30, 2025 | 861.20M |
| March 31, 2025 | 954.30M |
| December 31, 2024 | 1.039B |
| September 30, 2024 | 1.122B |
| June 30, 2024 | 1.234B |
| March 31, 2024 | 1.175B |
| December 31, 2023 | 1.266B |
| September 30, 2023 | 1.004B |
| June 30, 2023 | 1.044B |
| March 31, 2023 | 1.129B |
| December 31, 2022 | 1.211B |
| September 30, 2022 | 1.276B |
| June 30, 2022 | 1.348B |
| March 31, 2022 | 1.433B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.507B |
| September 30, 2021 | 1.549B |
| June 30, 2021 | 605.08M |
| March 31, 2021 | 651.27M |
| December 31, 2020 | 688.53M |
| September 30, 2020 | 248.56M |
| June 30, 2020 | 242.70M |
| March 31, 2020 | 262.83M |
| December 31, 2019 | 280.87M |
| September 30, 2019 | 190.51M |
| June 30, 2019 | 159.17M |
| March 31, 2019 | 174.96M |
| December 31, 2018 | 187.83M |
| September 30, 2018 | 89.79M |
| June 30, 2018 | 99.74M |
| March 31, 2018 | 112.70M |
| December 31, 2017 | 39.17M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 2.244M |
| CNBX Pharmaceuticals, Inc. | 0.0095M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 318.84M |
| Definium Therapeutics, Inc. | 1.084B |